Corporate Vice President and President, Global Surgical
John Barr is Executive Vice President and Global President of Bausch + Lomb's Surgical business.
was named to this post in May 2012, and reports to Bausch + Lomb
's President and CEO, Brent Saunders.
has extensive medical device and biotechnology industry experience spanning a wide variety of operational, strategy and customer-facing roles in which he
consistently increased company value and delivered business results.
At Bausch + Lomb
, Mr. Barr
has global responsibility for the company's full suite of ophthalmic surgical products, intraocular lenses (IOLs) and delivery systems, which include such brand names as enVista™ Crystalens®, Stellaris® PC, Storz™and VICTUS™.
Immediately prior to joining Bausch + Lomb, Barr was President and CEO of AGA Medical, a pioneer of minimally invasive devices to treat structural heart defects and vascular abnormalities.
leadership, AGA Medical
, which had been a Welsh Carson Anderson and Stowe-owned portfolio company, completed a successful IPO before ultimately being acquired by St. Jude Medical.
Barr also spent more than eight years at V.I. Technologies, an anti-infective therapeutics company as its President and COO.
Prior to joining V. I. Technologies, Barr spent seven years with Haemonetics, a manufacturer of blood processing technology, in a variety of customer service and operations roles before ultimately being named President of North American Operations.
Earlier in his career, Barr spent nearly 10 years at Baxter Healthcare in a number of financial and operational assignments culminating with his being promoted to Vice President of the company's healthcare IT solutions division, which ultimately merged with IBM Hospital Systems.
Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University in Evanston, IL where he earned his master's degree in Accounting and Economics.
He earned his undergraduate degree in Bioengineering from the University of Pennsylvania in Philadelphia, PA. Barr is also a former member of the Board of Directors for AdvaMed.